These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2201710)

  • 41. [Ventricular tachycardia and ventricular fibrillation following myocardial infarct: determinants of prognosis and disease course].
    Trappe HJ; Brugada P; Talajic M; Lezaun R; Wellens HJ
    Z Kardiol; 1988 Nov; 77(11):687-95. PubMed ID: 3213136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
    Wever EF; Hauer RN; van Capelle FL; Tijssen JG; Crijns HJ; Algra A; Wiesfeld AC; Bakker PF; Robles de Medina EO
    Circulation; 1995 Apr; 91(8):2195-203. PubMed ID: 7697849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic study.
    Kim SG; Aboaf AP; Roth J; Ferrick K; Fisher JD
    Am Heart J; 1991 Jan; 121(1 Pt 1):77-80. PubMed ID: 1985381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lethal outcomes in patients with symptomatic heart failure developed after Q-wave myocardial infarction.
    Zaliūnas R; Babarskiene MR; Kavoliūniene A; Slapikiene B; Luksiene D; Slapikas R; Vencloviene J
    Medicina (Kaunas); 2004; 40(2):141-8. PubMed ID: 15007273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Programmed ventricular stimulation after myocardial infarction does not help reduce the risk of ventricular events.
    Brembilla-Perrot B; Jacquemin L; Terrier de la Chaise A; Beurrier D
    Cardiovasc Drugs Ther; 1996 Nov; 10(5):549-56. PubMed ID: 8950069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphous ventricular tachycardia associated with acute myocardial infarction.
    Wolfe CL; Nibley C; Bhandari A; Chatterjee K; Scheinman M
    Circulation; 1991 Oct; 84(4):1543-51. PubMed ID: 1914096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late clinical outcome in patients with early ventricular fibrillation after myocardial infarction.
    Nicod P; Gilpin E; Dittrich H; Wright M; Engler R; Rittlemeyer J; Henning H; Ross J
    J Am Coll Cardiol; 1988 Mar; 11(3):464-70. PubMed ID: 3343451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Could sustained monomorphic ventricular tachycardia in the early phase of a prime acute myocardial infarction affect patient outcome?
    Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Mavridis A; Papanas N; Chalikias G; Maltezos E; Hatseras DI
    J Electrocardiol; 2007 Jan; 40(1):72-7. PubMed ID: 17070829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained ventricular tachyarrhythmias during the early postinfarction period: electrophysiologic findings and prognosis for survival.
    Marchlinski FE; Waxman HL; Buxton AE; Josephson ME
    J Am Coll Cardiol; 1983 Aug; 2(2):240-50. PubMed ID: 6863760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction.
    Perkiömäki JS; Huikuri HV; Koistinen JM; Mäkikallio T; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1997 Nov; 30(5):1331-8. PubMed ID: 9350936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late development of intractable ventricular tachycardia after acute myocardial infarction.
    Sehapayak GK; Watson JT; Curry GC; Londe SP; Mullins CB; Willerson JT; Sugg WL
    J Thorac Cardiovasc Surg; 1974 May; 67(5):818-25. PubMed ID: 4823316
    [No Abstract]   [Full Text] [Related]  

  • 57. [Role of spectral turbulence analysis of ECG in predicting risk of arrhythmia after myocardial infarction].
    Vado A; Bruna C; Rossetti G; Isoardi D; Cherasco E; Borello W; Uslenghi E
    G Ital Cardiol; 1997 Jul; 27(7):674-81. PubMed ID: 9303857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.
    Hohnloser SH; Klingenheben T; Zabel M; Schöpperl M; Mauss O
    J Am Coll Cardiol; 1999 Jun; 33(7):1895-902. PubMed ID: 10362190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
    Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical management of sustained ventricular arrhythmias presenting within eight weeks of acute myocardial infarction.
    Kron IL; Lerman B; DiMarco JP
    Ann Thorac Surg; 1986 Jul; 42(1):13-6. PubMed ID: 3729611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.